PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease

Frontiers in Molecular Neuroscience
Francois Mouton-LigerOlga Corti

Abstract

Parkinson's disease (PD) is one of the most frequent neurodegenerative disease caused by the preferential, progressive degeneration of the dopaminergic (DA) neurons of the substantia nigra (SN) pars compacta. PD is characterized by a multifaceted pathological process involving protein misfolding, mitochondrial dysfunction, neuroinflammation and metabolism deregulation. The molecular mechanisms governing the complex interplay between the different facets of this process are still unknown. PARK2/Parkin and PARK6/PINK1, two genes responsible for familial forms of PD, act as a ubiquitous core signaling pathway, coupling mitochondrial stress to mitochondrial surveillance, by regulating mitochondrial dynamics, the removal of damaged mitochondrial components by mitochondria-derived vesicles, mitophagy, and mitochondrial biogenesis. Over the last decade, PINK1/Parkin-dependent mitochondrial quality control emerged as a pleiotropic regulatory pathway. Loss of its function impinges on a number of physiological processes suspected to contribute to PD pathogenesis. Its role in the regulation of innate immunity and inflammatory processes stands out, providing compelling support to the contribution of non-cell-autonomous immune mechanisms in...Continue Reading

References

Oct 1, 1991·Brain : a Journal of Neurology·J M Fearnley, A J Lees
Oct 15, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Sep 19, 2000·Journal of Neurology·H Braak, E Braak
Jun 18, 2002·Journal of Neurochemistry·Lucia CarvelliAurelio Galli
Aug 29, 2002·The EMBO Journal·Quan ZhaoNicholas J Hoogenraad
May 6, 2003·Annals of Neurology·Honglei ChenAlberto Ascherio
Dec 17, 2003·Neurobiology of Aging·Heiko Braak, Kelly Del Tredici
Jan 23, 2004·Nature·Marcelo T MiraErwin Schurr
Apr 8, 2004·Molecular Cell·Ronald A Butow, Narayan G Avadhani
Jul 6, 2004·Annals of Neurology·Kim TieuSerge Przedborski
Sep 1, 2004·Cell and Tissue Research·Heiko BraakKelly Del Tredici
May 21, 2005·Journal of Neurocytology·Richard B BanatiManuel B Graeber
Sep 27, 2005·Neurobiology of Disease·Alexander GerhardDavid J Brooks
Jun 17, 2006·The EMBO Journal·Naotada IshiharaKatsuyoshi Mihara
Feb 23, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iris H HennKonstanze F Winklhofer
Oct 2, 2007·Nature Cell Biology·Hélène Plun-FavreauJulian Downward
Jan 22, 2008·Current Biology : CB·Margaret NeuspielHeidi M McBride
Apr 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Xuemei HuangG Webster Ross
Apr 4, 2008·Journal of Neurochemistry·Rajnish K Chaturvedi, M Flint Beal
Oct 24, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tamy C Frank-CannonMalú G Tansey
Nov 26, 2008·The Journal of Cell Biology·Derek NarendraRichard J Youle
Jan 23, 2009·Nature Cell Biology·Xiaowen WangXin Jie Chen
Mar 20, 2009·Lancet Neurology·Etienne C Hirsch, Stéphane Hunot
Apr 11, 2009·The EMBO Journal·Daniel TonderaJean-Claude Martinou
Jun 24, 2009·The Journal of Biological Chemistry·A Kathrin LutzKonstanze F Winklhofer
Aug 20, 2009·Science Signaling·Kai YasukawaTakumi Koshiba
Feb 4, 2010·PLoS Biology·Derek P NarendraRichard J Youle
Mar 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Elena ZivianiAlexander J Whitworth
May 21, 2010·Autophagy·Cristofol Vives-Bauza, Serge Przedborski
May 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Juan-Carlos Rodríguez-PradosLisardo Boscá

❮ Previous
Next ❯

Citations

Nov 8, 2017·International Journal of Molecular Sciences·Qiuyun WuChunhui Ni
Feb 8, 2018·Molecular Neurobiology·Laura KayMeera Soundararajan
Jul 17, 2019·Proceedings of the National Academy of Sciences of the United States of America·Vinicius M FavaErwin Schurr
Aug 22, 2018·EMBO Molecular Medicine·Gloria M PalomoGiovanni Manfredi
Oct 27, 2017·Journal of Neuroscience Research·Neeraj Joshi, Sarika Singh
Jan 13, 2018·Molecular Medicine Reports·Huiying QiaoRong Lv
Oct 16, 2018·Frontiers in Immunology·Tianfang JiangXu Chen
Nov 5, 2019·The Journal of Physiological Sciences : JPS·Ramada R KhasawnehHadeel Abu-El-Rub
Mar 10, 2020·Journal of Neurochemistry·Olga CortiPhilip M Beart
May 28, 2020·International Journal of Molecular Sciences·Mark F McCarty, Aaron Lerner
Jul 14, 2020·Frontiers in Cellular Neuroscience·Xu YanXinwen Zhang
Nov 2, 2017·Translational Neurodegeneration·Panchanan MaitiGary L Dunbar
Dec 23, 2017·Frontiers in Cell and Developmental Biology·Kiran TodkarMarc Germain
Sep 10, 2019·F1000Research·Douglas M LopesStephen B McMahon
Jan 17, 2020·Cells·Maria-Eleni Anagnostou, Russell T Hepple
May 19, 2019·Neurotoxicity Research·Olga Corti
Jun 4, 2019·Frontiers in Physiology·Mafalda Escobar-Henriques, Mariana Joaquim
Oct 20, 2020·Journal of Parkinson's Disease·Max BorscheAnne Grünewald
Oct 22, 2020·Antioxidants·E Maruthi Prasad, Shih-Ya Hung
Jan 31, 2021·Communications Biology·Philippe FernandesValeria Naim
Feb 19, 2021·Metabolic Brain Disease·Vandana ZamanNarendra L Banik
Apr 6, 2021·Archives of Biochemistry and Biophysics·Esha SircarRajib Sengupta
May 22, 2021·Journal of Agricultural and Food Chemistry·Yilong CuiYanfei Li
Jul 20, 2021·Frontiers in Integrative Neuroscience·María GamarraJimena Baleriola
Aug 25, 2021·Therapeutic Advances in Respiratory Disease·Hui YongJicheng Wei
Apr 14, 2019·Life Sciences·Chand RazaNoor Ul Ain Shakeel
Apr 27, 2021··Wenjie You

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensor
GTPase
transgenic
protein folding

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Antioxidants & Redox Signaling
Terina N Martinez, J Timothy Greenamyre
Movement Disorders : Official Journal of the Movement Disorder Society
Shin-ichiro KuboYoshikuni Mizuno
Current Drug Targets. CNS and Neurological Disorders
Sandra M CardosoCatarina R Oliveira
Antioxidants & Redox Signaling
Aracely Garcia-GarciaRodrigo Franco
© 2022 Meta ULC. All rights reserved